UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
18.59
-0.14 (-0.75%)
Mar 17, 2026, 4:00 PM EDT - Market closed
UroGen Pharma Market Cap
UroGen Pharma has a market cap or net worth of $904.03 million as of March 17, 2026. Its market cap has increased by 126.46% in one year.
Market Cap
904.03M
Enterprise Value
918.53M
1-Year Change
126.46%
Ranking
Category
Stock Price
$18.59
Market Cap Chart
Since May 4, 2017, UroGen Pharma's market cap has increased from $181.90M to $904.03M, an increase of 396.99%. That is a compound annual growth rate of 19.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 911.80M | -16.83% |
| Dec 31, 2025 | 1.10B | 143.95% |
| Dec 31, 2024 | 449.40M | -2.94% |
| Dec 29, 2023 | 463.00M | 126.07% |
| Dec 30, 2022 | 204.80M | -3.94% |
| Dec 31, 2021 | 213.20M | -46.45% |
| Dec 31, 2020 | 398.10M | -43.14% |
| Dec 31, 2019 | 700.10M | 18.24% |
| Dec 31, 2018 | 592.10M | 22.31% |
| Dec 29, 2017 | 484.10M | 166.14% |
| May 4, 2017 | 181.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 941.47M |
| Compass Therapeutics | 934.66M |
| GH Research | 927.34M |
| Valneva SE | 911.69M |
| Sana Biotechnology | 896.67M |
| SpyGlass Pharma | 884.58M |
| Adlai Nortye | 880.07M |
| Xencor | 880.06M |